A Randomized Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients with Intermediate and Poor-Risk Germ Cell Tumors

Sponsor:

COG

Sponsor Study ID:

AGCT1532

CTO #:

103096

NCT Number:

NCT02582697

Phase:

III

Protocol Type:

Treatment

Age Group:

Both

Disease Sites:

Other Female Genital; Other Male Genital; Soft Tissue

Study Objectives:

The purpose of this study is to determine whether accelerated BEP chemotherapy is more effective than standard BEP chemotherapy in males with intermediate and poor-risk metastatic germ cell tumours.

eConsent:

Not available

Study Documents:

Open Study Documents
(MUSC NetID required for document access)